How do I read and understand my Ovarian Cancer pathology report

Understanding Your Ovarian Cancer Pathology Report

A pathology report is one of the most important documents in your cancer care—it describes what the pathologist found when examining your tissue under a microscope. Let me walk you through what to look for and what it means.

THE MAIN SECTIONS YOU'LL SEE

1. SPECIMEN DESCRIPTION

This section describes what tissue was removed and examined.

What to look for:

• Tumor site(s): Where the cancer was found (ovary, fallopian tube, peritoneum, or other areas)
• Tumor size(s): The dimensions of the cancer
• Specimen integrity: Whether the tissue capsule (outer lining) was intact or ruptured

Why this matters: According to NCCN Guidelines, if the ovarian capsule was ruptured during surgery, this can affect staging and treatment decisions. Your doctor will want to know this information.

2. HISTOLOGIC TYPE AND GRADE

This tells you what kind of cancer it is and how aggressive it appears.

Common ovarian cancer types:

• Serous carcinoma (most common)
• Mucinous carcinoma (less common)
• Endometrioid carcinoma (often associated with endometriosis)
• Clear cell carcinoma (high-grade, may arise from endometriosis)

Grade explanation:

• Grade 1 (Low-grade): Cancer cells look more like normal cells; slower growing
• Grade 2 (Intermediate): Moderately abnormal appearance
• Grade 3 (High-grade): Very abnormal appearance; faster growing

Why this matters: Grade helps predict how the cancer may behave and influences treatment recommendations.

3. EXTENSION AND IMPLANTS

This describes how far the cancer has spread within the pelvis and abdomen.

Key findings:

• Peritoneal implants: Spots where cancer has spread to the lining of the abdomen
• Lymph node involvement: Whether cancer reached nearby lymph nodes
• Other organ involvement: Spread to uterus, bowel, liver, etc.

Why this matters: This information is crucial for staging (determining how advanced the cancer is) and planning treatment.

4. CYTOLOGY RESULTS

This describes fluid samples taken during surgery.

What to look for:

• Peritoneal/ascitic fluid: Fluid from the abdomen
• Pleural fluid: Fluid from around the lungs (if sampled)
• Results will say whether cancer cells were found

Why this matters: Finding cancer cells in fluid indicates more advanced disease and affects staging and treatment.

5. LYMPH NODE ASSESSMENT

This is critical information about whether cancer spread to lymph nodes.

What to look for:

• Number of lymph nodes examined: How many were removed and checked
• Number with cancer: How many contained cancer cells
• Size of largest deposit: The biggest area of cancer found in a node

Why this matters: Lymph node involvement affects staging and may influence whether you need additional treatment.

---

MOLECULAR TESTING RESULTS (VERY IMPORTANT)

According to NCCN Guidelines, your pathology report should include results for specific genetic markers that directly affect your treatment options:

BRCA1/2 Status

• What it is: A genetic mutation that affects how your cancer cells repair DNA
• Why it matters: If you have a BRCA mutation, you may be eligible for PARP inhibitor therapy (a targeted treatment that works specifically on BRCA-mutated cancers)
• What to look for: "BRCA1 mutation," "BRCA2 mutation," or "BRCA wild-type" (meaning no mutation found)

Homologous Recombination Deficiency (HRD) Status

• What it is: A measure of how well your cancer cells can repair DNA damage
• Why it matters: Even without a BRCA mutation, HRD status helps predict whether PARP inhibitors might help
• What to look for: "HRD-positive" or "HRD-negative"

Other Molecular Markers (especially if you have less common ovarian cancer types)

The NCCN Guidelines recommend testing for:

• MSI (Microsatellite Instability) and MMR (Mismatch Repair): May indicate eligibility for immunotherapy
• HER2 status: Relevant for some ovarian cancers
• BRAF, NTRK, FRα (FOLR1): May indicate targeted therapy options

Why this matters: These tests identify specific vulnerabilities in your cancer that doctors can target with precision medicines.

---

STAGING INFORMATION

Your pathology report should include FIGO staging (the standard system for ovarian cancer):

• Stage I: Cancer limited to one or both ovaries
• Stage II: Cancer involves ovaries plus other pelvic structures
• Stage III: Cancer involves ovaries plus abdominal peritoneum and/or lymph nodes
• Stage IV: Cancer has spread to distant organs (liver, lungs, etc.)

Each stage is further divided (A, B, C) based on extent of spread.

---

SPECIAL FINDINGS TO DISCUSS WITH YOUR DOCTOR

According to NCCN Guidelines, ask your doctor about these if they appear in your report:

1. STIC (Serous Tubal Intraepithelial Carcinoma): Early cancer in the fallopian tube
2. Endometriosis: Tissue lining the uterus found in abnormal locations (relevant for certain cancer types)
3. Borderline tumors (LMP tumors): Low malignant potential tumors that behave differently than invasive cancer
4. Pattern of invasion: For mucinous cancers, whether the pattern is "expansile" (pushing outward) or "infiltrative" (invading destructively)—this affects prognosis and treatment

---

QUESTIONS TO ASK YOUR ONCOLOGIST

Now that you understand the sections, here are specific questions to ask:

1. "Based on my pathology results, what stage is my cancer, and what does that mean for my treatment?"

2. "Do I have BRCA mutations or HRD status? If so, what treatment options does this open up for me?"

3. "Were there any unexpected findings in my pathology report that change the treatment approach?"

4. "If my pathology report mentions a ruptured capsule or peritoneal implants, how does this affect my treatment plan?"

5. "Should I have any additional molecular testing done that wasn't included in this initial report?"

6. "Can you explain what my grade and histologic type mean for my prognosis?"

---

KEY TAKEAWAY

Your pathology report is a detailed map of your cancer. The histologic type, grade, stage, and molecular markers are the most important pieces because they directly guide treatment decisions. Don't hesitate to ask your oncologist to explain any terms you don't understand—this is your health, and you deserve clarity.

According to NCCN Guidelines, if you have any equivocal (unclear) findings in your pathology report, you have the right to request that your pathology be reviewed by pathologists at specialized cancer centers for confirmation.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.